USA£º(540) 808-3925
China£º400-117-0038
Ireland
Shopping Cart
Sign in \ Register
Cariporide (CAS: 159138-80-4)
Catalog #£ºEBC51114
  SKU-Pack Size Availability Size Price
EBC51114-1ML In Stock 1mL(10mM in DMSO) €89.70
EBC51114-5MG In Stock 5mg €89.70
EBC51114-10MG In Stock 10mg €115.70
EBC51114-25MG In Stock 25mg €232.70
EBC51114-50MG In Stock 50mg €479.70
If you want to get a larger packsize, Please contact your local distributor or
email us atinfo@ebiocell.com
Please Select The Country You Are In To Find Your Local Distributor.
Cambiotech Phone£º+44 (0) 188 448801
Lanwades Business Park, E-mail£ºinfo@cambiotech.com
Ireland Kobenhavn K, Ireland Web£ºwww.cambiotech.com
Product Information
Synonym(s) HOE-642, HOE 642
Chemical Name N-(Diaminomethylene)-4-isopropyl-3-(methylsulfonyl)benzamide
Application Cariporide is an NHE-1 inhibitor that blocks apoptosis in cardiac muscle cells
CAS Number 159138-80-4
Purity ¡Ý98.0%
Molecular Weight 283.35
Molecular Formula C₁₂H₁₇N₃O₃S
SMILES DMSO: 79 mg/mL (278.8 mM)
Target & IC50 Sodium/hydrogen exchanger : IC50 = 26 nM
Solubility DMSO: 79 mg/mL (278.8 mM)
Preparing Stock Solutions
ConcentrationSolventMass 1 mg 5 mg 10 mg
1 mM 3.5292 ml 17.6460 ml 35.2920 ml
5 mM 0.7058 ml 3.5292 ml 7.0584 ml
10 mM 0.3529 ml 1.7646 ml 3.5292 ml
50 mM 0.0706 ml 0.3529 ml 0.7058 ml
Shipping Gel Pack
Storage Store at -20¡ãC
Research Use For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use.
Product Description

Cariporide (HOE-642), an effective NHE1 inhibitor, has inhibitory effects on the degranulation of human platelets, the formation of platelet-leukocyte-aggregates, and the activation of the GPIIb/IIIa receptor (PAC-1).

Specific Protocols
>> Western Blotting Protocol >> Immunoprecipitation Protocol
>> Immunohistochemistry Protocol >> Immunofluorescence Protocol
>> Immunocytochemistry Protocol >> Flow Cytometry Protocol
>> ChIP Protocol >> ELISA Protocol
>> HPLC Protocol >> PCR Protocol
For Research Use Only, Not For Diagnostic Or Therapeutic Procedures.
Copyright 2015 EbioCell, Inc. All Rights Reserved. ¡¡±¸°¸ºÅ£º½òICP±¸2022005142ºÅ-1